Gareth Sanger

Gareth J. Sanger (born 1953) is a British pharmacologist.

Gareth Sanger
NationalityUnited Kingdom
Employers
Websitewww.icms.qmul.ac.uk/neurogastro/staff/garethsanger.html

Sanger was a research fellow at King's College Hospital Medical School from 1977 to 1990.[1] He then spent a period in the pharmacological industry,[1] before being appointed, in 2009, Professor of Neuropharmacology, at Queen Mary University of London.[2]

He has served as editor and reviews editor for the "British Journal of Pharmacology" and as an editorial board member for "Drug Discovery Today".[1]

Together with M Tyers he received the 1998 Pharmaceutical Research and Manufacturers of America (PhRMA) "Discoverer's Award" for their research into 5HT3 receptor/antiemesis, which led to the identification and development of the drug Kytril,[1][2] an antiemetic to treat nausea and vomiting following chemotherapy.

References
  1. Daphne Christie; Tilli Tansey, eds. (2007). The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-85484-112-7. OL 25554713M. Wikidata Q29581749.
  2. "Gareth Sanger". The Conversation. Retrieved 26 June 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.